Welcome to our dedicated page for Mynaric SEC filings (Ticker: MYNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Mynaric’s laser communication business moves at the speed of light—unfortunately, its SEC reports don’t. Multi-year R&D expenses, contract backlog disclosures, and export-control footnotes make each filing a challenge.
Stock Titan solves that problem. Our AI scans every Mynaric quarterly earnings report 10-Q filing and Mynaric annual report 10-K simplified, surfacing the data points investors hunt for: optical-terminal margins, unit shipment milestones, and cash used for factory build-outs. Need real-time alerts? Follow Mynaric Form 4 insider transactions real-time to see when engineers, executives, or early backers buy or sell shares. Curious about governance? We translate the Mynaric proxy statement executive compensation tables into clear totals, then link them to option-grant performance metrics.
Common questions are answered directly inside each document tab:
- “Mynaric insider trading Form 4 transactions” – instant feeds with downloadable spreadsheets
- “Mynaric 8-K material events explained” – AI-written briefs showing contract wins or launch delays
- “Understanding Mynaric SEC documents with AI” – side-by-side views of the original text and our plain-English commentary
- “Mynaric earnings report filing analysis” – automated charts comparing R&D spend to backlog growth
Whether you’re modeling cash burn, tracking Mynaric executive stock transactions Form 4, or looking for satellite-constellation revenue guidance, all filings arrive from EDGAR in seconds. Stock Titan’s expert layer then highlights what matters and saves hours otherwise lost in technical PDFs. Access every form—10-K, 10-Q, 8-K, S-1, and more—plus insider activity, all in one place, already explained simply.
Mynaric AG has submitted Form 25-NSE to notify its removal from listing and/or registration on the Nasdaq Stock Market LLC. The delisting affects the company's American Depository Shares (ADS).
Key details of the notification:
- Filing Date: June 28, 2025
- Commission File Number: 001-41045
- Company headquarters: Gilching, Germany
- The delisting process is being conducted pursuant to Exchange rules and requirements under 17 CFR 240.12d2-2(b)
The Form 25 was signed by Aravind Menon, Hearings Advisor, on June 23, 2025. This delisting action represents a significant change in Mynaric's market presence and accessibility to U.S. investors, as it will no longer be traded on the Nasdaq exchange.